Literature DB >> 15496326

Use of in situ FT-Raman spectroscopy to study the kinetics of the transformation of carbamazepine polymorphs.

Laura E O'Brien1, Peter Timmins, Adrian C Williams, Peter York.   

Abstract

The solid-state transformation of carbamazepine from form III to form I was examined by Fourier Transform Raman spectroscopy. Using a novel environmental chamber, the isothermal conversion was monitored in situ at 130 degrees C, 138 degrees C, 140 degrees C and 150 degrees C. The rate of transformation was monitored by taking the relative intensities of peaks arising from two CH bending modes; this approach minimised errors due to thermal artefacts and variations in power intensities or scattering efficiencies from the samples in which crystal habit changed from a characteristic prism morphology (form III) to whiskers (form I). The solid-state transformation at the different temperatures was fitted to various solid-state kinetic models of which four gave good fits, thus indicating the complexity of the process which is known to occur via a solid-gas-solid mechanism. Arrhenius plots from the kinetic models yielded activation energies from 344 kJ mol(-1) to 368 kJ mol(-1) for the transformation. The study demonstrates the value of a rapid in situ analysis of drug polymorphic type which can be of value for at-line in-process control.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15496326     DOI: 10.1016/j.jpba.2004.06.024

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Characterization of the distribution, polymorphism, and stability of nimodipine in its solid dispersions in polyethylene glycol by micro-Raman spectroscopy and powder X-ray diffraction.

Authors:  Aristides Docoslis; Krista L Huszarik; George Z Papageorgiou; Dimitrios Bikiaris; Dimitrios Stergiou; E Georgarakis
Journal:  AAPS J       Date:  2007-12-07       Impact factor: 4.009

2.  Self-built supercritical CO2 anti-solvent unit design, construction and operation using carbamazepine.

Authors:  Dan Meng; James Falconer; Karen Krauel-Goellner; John J J J Chen; Mohammed Farid; Raid G Alany
Journal:  AAPS PharmSciTech       Date:  2008-08-09       Impact factor: 3.246

3.  A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.

Authors:  Siyuan Huang; Kevin P O'Donnell; Justin M Keen; Mark A Rickard; James W McGinity; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2015-09-04       Impact factor: 3.246

4.  Visualizing solvent mediated phase transformation behavior of carbamazepine polymorphs by principal component analysis.

Authors:  Fang Tian; Thomas Rades; Niklas Sandler
Journal:  AAPS PharmSciTech       Date:  2008-02-21       Impact factor: 3.246

5.  Monitoring real time polymorphic transformation of sulfanilamide by diffuse reflectance visible spectroscopy.

Authors:  Tracy O Ehiwe; Bruce D Alexander; John C Mitchell; Martin J Snowden; Laura J Waters
Journal:  J Pharm Anal       Date:  2016-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.